Checked
Azitra, Inc.
NYSE: AZTR · Pharmaceutical Preparations · Branford, CT
- Revenue
- $0
- -100.0% vs. prior year
- Net income
- -$10.96M
- Total assets
- $5.03M
- Diluted EPS
- -$2.25
Company details
As reported to the SEC
- SEC CIK
- 1701478
- Stock
- NYSE: AZTR
- Industry (SIC)
- Pharmaceutical Preparations (2834)
- Headquarters
- 21 Business Park Drive, Suite 6, Branford, CT 06405
- Incorporated in
- Delaware
- Fiscal year end (SEC record)
- December 31
- Filer status
- , Emerging growth company
- Phone
- (203) 489-0183
- Employer ID (EIN)
- 46-4478536
- Last annual report
- 02/27/2026
- Last quarterly report
- 08/12/2026
Formerly: Azitra Inc (until 01/04/2024)
Annual financials
U.S. dollars, as tagged in each annual report's XBRL data. Later restatements replace earlier numbers. Select a date to open the filing.
| Fiscal year ended | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 |
|---|---|---|---|---|
| Revenue | $0 | $7.5K | $686K | $284K |
| Operating income | -$10.97M | -$10.99M | -$7.45M | -$9.45M |
| Net income | -$10.96M | -$8.97M | -$11.28M | -$10.68M |
| Diluted earnings per share | -$2.25 | -$15.70 | -$54.98 | -$12.74 |
| Research and development | $4.84M | $4.72M | $3.64M | $6.1M |
| Total assets | $5.03M | $7.36M | $5.12M | $7.17M |
| Total liabilities | $1.22M | $1.66M | $2.2M | $9.73M |
| Shareholders' equity | $3.8M | $5.7M | $2.91M | -$36.26M |
| Cash and cash equivalents | $2.07M | $4.55M | $1.8M | $3.49M |
| Cash from operations | -$11.22M | -$10.18M | -$7.36M | -$8.35M |
| Capital expenditures | $24.21K | $8.57K | $26.54K | $33.1K |
Recent filings
98 recent filings on record; insider ownership forms (3, 4, 5 and 144) are not listed here
Swipe the table sideways to see more columns.
| Form | Filed | Period |
|---|---|---|
| 8-KOther events | 10/26/2026 | 10/26/2026 |
| 8-KChange to shareholder rights, Bylaws or fiscal year change | 10/22/2026 | 10/22/2026 |
| 8-KOther events | 10/01/2026 | 10/01/2026 |
| 8-KMaterial agreement | 09/28/2026 | 09/28/2026 |
| 424B5Prospectus supplement | 09/28/2026 | None |
| 8-KRegulation FD disclosure | 09/08/2026 | 09/08/2026 |
| 8-KOther events | 08/21/2026 | 08/21/2026 |
| SCHEDULE 13GOwnership report (5% holder, passive) | 08/14/2026 | None |
| SCHEDULE 13GOwnership report (5% holder, passive) | 08/14/2026 | None |
| 8-KResults of operations | 08/12/2026 | 08/12/2026 |
| 10-QQuarterly report | 08/12/2026 | 06/30/2026 |
| 8-KOther events | 07/15/2026 | 07/15/2026 |
| SCHEDULE 13GOwnership report (5% holder, passive) | 06/25/2026 | None |
| SCHEDULE 13DOwnership report (5% holder, active) | 06/24/2026 | None |
| SCHEDULE 13GOwnership report (5% holder, passive) | 06/22/2026 | None |
| 8-KOther events | 06/17/2026 | 06/17/2026 |
| 8-KBylaws or fiscal year change, Shareholder vote results | 06/16/2026 | 06/15/2026 |
| DEFA14AAdditional proxy materials | 06/04/2026 | None |
| 8-KOther events | 06/04/2026 | 06/04/2026 |
| EFFECTNotice of effectiveness | 06/02/2026 | None |
10 insider ownership reports (Forms 3, 4, 5 and 144) were filed about Azitra, Inc. in the last 12 months. They list trades by officers, directors and large holders; see them on SEC EDGAR.
Other pharmaceutical preparations
Swipe the table sideways to see more columns.
| Company | Headquarters | Revenue | Net income |
|---|---|---|---|
| Johnson & JohnsonJNJ | New Brunswick, NJ | $94.19B | $26.8B |
| Eli Lilly & CoLLY | Indianapolis, IN | $65.18B | $20.64B |
| Merck & Co., Inc.MRK | Rahway, NJ | $65.01B | $18.25B |
| Pfizer IncPFE | New York, NY | $62.58B | $7.77B |
| AbbVie Inc.ABBV | North Chicago, IL | $61.16B | $4.23B |
| Astrazeneca PLCAZN | Cambridge, United Kingdom | $58.74B | $10.22B |
| Bristol Myers Squibb CoBMY | Princeton, NJ | $48.19B | $7.05B |
| Abbott LaboratoriesABT | Abbott Park, IL | $44.33B | $6.52B |
Profile refreshed Oct 26, 2026; financials refreshed Oct 22, 2026.
Frequently asked questions
- What is Azitra, Inc.'s CIK number?
- Azitra, Inc.'s SEC Central Index Key (CIK) is 1701478.
- What is Azitra, Inc.'s stock ticker?
- Azitra, Inc. trades as NYSE: AZTR.
- What was Azitra, Inc.'s revenue?
- Azitra, Inc. reported revenue of $0 for the fiscal year ended Dec 31, 2025, -100.0% from the year before.
- When does Azitra, Inc.'s fiscal year end?
- Azitra, Inc.'s fiscal year end on file with the SEC is December 31; its most recent fiscal year ended Dec 31, 2025.
- Where is Azitra, Inc. headquartered?
- Azitra, Inc.'s principal executive office on file with the SEC is in Branford, CT.
Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026